The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Frontiers in cancer nanomedicine: directing mass transport through biological barriers
Open accessAbstract
The physics of mass transport within body compartments and across biological barriers differentiates cancers from healthy tissues. Variants of nanoparticles can be manufactured in combinatorially large sets, varying only one transport-affecting design parameter at a time. Nanoparticles can also be used as building blocks for systems that perform sequences of coordinated actions, in accordance to a prescribed logic. These are referred to as Logic-Embedded Vectors “(LEV)” in the following. Nanoparticles and LEVs are ideal probes for the determination of mass transport laws in tumors, acting as imaging contrast enhancers, and can be employed for the lesion-selective delivery of therapy. Their size, shape, density and surface chemistry dominate convective transport in the blood stream, margination, cell adhesion, selective cellular uptake, as well as sub-cellular trafficking and localization. As argued here, the understanding of transport differentials in cancer, termed ‘transport oncophysics’ unveils a new promising frontier in oncology: the development of lesion-specific delivery particulates that exploit mass transport differentials to deploy treatment of greater efficacy and reduced side effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited
Fidler, I. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1098 · Cited by 4,686 · cited 1×
“Cancer is s a disease of the cell, which is inextricably linked to its surrounding biological milieu through a complexity of interactions with its microenvironment and distant sites within the host organism [1,2].”
BackgroundCancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558
Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance
Hirsch, L. R., Stafford, R. J., Bankson, J. A., Sershen, S. R., Rivera, B., Price, R. E., Hazle, J. D., Halas, N. J., & West, J. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2232479100 · Cited by 3,955
The dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
Drug penetration in solid tumours
Minchinton, A. I., & Tannock, I. F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1893 · Cited by 2,805
Nanoparticles in Medicine: Therapeutic Applications and Developments
Zhang, L., Gu, F., Chan, J., Wang, A., Langer, R., & Farokhzad, O. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100400 · Cited by 2,657
Maeda, H. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00013-3 · Cited by 2,495
Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438
Kam, N. W. S., O'Connell, M., Wisdom, J. A., & Dai, H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502680102 · Cited by 2,307
(2016) · CRC Press eBooks · doi:10.1201/b12801 · Cited by 2,031
A tense situation: forcing tumour progression
Butcher, D. T., Alliston, T., & Weaver, V. M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2544 · Cited by 1,940
Exploiting the enhanced permeability and retention effect for tumor targeting
Iyer, A. K., Khaled, G., Fang, J., & Maeda, H. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.07.005 · Cited by 1,846
Immunotargeted Nanoshells for Integrated Cancer Imaging and Therapy
Loo, C., Lowery, A., Halas, N., West, J., & Drezek, R. (2005) · Nano Letters · doi:10.1021/nl050127s · Cited by 1,792
Signaling Mechanisms Regulating Endothelial Permeability
Mehta, D., & Malik, A. B. (2006) · Physiological Reviews · doi:10.1152/physrev.00012.2005 · Cited by 1,720
Nanoshell-Enabled Photothermal Cancer Therapy: Impending Clinical Impact
Lal, S., Clare, S. E., & Halas, N. J. (2008) · Accounts of Chemical Research · doi:10.1021/ar800150g · Cited by 1,625
Nanomedicine—Challenge and Perspectives
Riehemann, K., Schneider, S. W., Luger, T. A., Godin, B., Ferrari, M., & Fuchs, H. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200802585 · Cited by 1,305
Self-citationRole of extracellular matrix assembly in interstitial transport in solid tumors.
Netti, P. A., Berk, D. A., Swartz, M. A., Grodzinsky, A. J., & Jain, R. K. (2000) · PubMed · Cited by 1,165
Size and shape effects in the biodistribution of intravascularly injected particles
Decuzzi, P., Godin, B., Tanaka, T., Lee, S.-Y., Chiappini, C., Liu, X., & Ferrari, M. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.014 · Cited by 965
Self-citationPharmacokinetic and biodistribution properties of poly(ethylene glycol)–protein conjugates
Caliceti, P. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(03)00108-x · Cited by 947
Mechanics, malignancy, and metastasis: The force journey of a tumor cell
Kumar, S., & Weaver, V. M. (2009) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9173-4 · Cited by 928
Yuan, F., Leunig, M., Huang, S. K., Berk, D. A., Papahadjopoulos, D., & Jain, R. K. (1994) · PubMed · Cited by 908
Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation
Brown, E., McKee, T., diTomaso, E., Pluen, A., Seed, B., Boucher, Y., & Jain, R. K. (2003) · Nature Medicine · doi:10.1038/nm879 · Cited by 836
Maier-Hauff, K., Rothe, R., Scholz, R., Gneveckow, U., Wust, P., Thiesen, B., Feussner, A., von Deimling, A., Waldoefner, N., Felix, R., et al. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-006-9195-0 · Cited by 775
Albumin-bound paclitaxel: a next-generation taxane
Gradishar, W. J. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.8.1041 · Cited by 712
Transport of Molecules, Particles, and Cells in Solid Tumors
Jain, R. K. (1999) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.1.1.241 · Cited by 691
Tasciotti, E., Liu, X., Bhavane, R., Plant, K., Leonard, A. D., Price, B. K., Cheng, M. M.-C., Decuzzi, P., Tour, J. M., Robertson, F., et al. (2008) · Nature Nanotechnology · doi:10.1038/nnano.2008.34 · Cited by 668
Self-citationFundamental Concepts of the Angiogenic Process
Folkman, J. (2003) · Current Molecular Medicine · doi:10.2174/1566524033479465 · Cited by 666
Integrin signaling and cell growth control
Howe, A., Aplin, A. E., Alahari, S. K., & Juliano, R. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80144-0 · Cited by 654
Intravascular Delivery of Particulate Systems: Does Geometry Really Matter?
Decuzzi, P., Pasqualini, R., Arap, W., & Ferrari, M. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9697-x · Cited by 616
Self-citationPluen, A., Boucher, Y., Ramanujan, S., McKee, T. D., Gohongi, T., di Tomaso, E., Brown, E. B., Izumi, Y., Campbell, R. B., Berk, D. A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081626898 · Cited by 603
Langer, R. (2001) · Science · doi:10.1126/science.1063273 · Cited by 579
Delivery of Novel Therapeutic Agents in Tumors: Physiological Barriers and Strategies
Jain, R. K. (1990) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/81.8.570 · Cited by 557
RECENT APPROACHES TO INTRACELLULAR DELIVERY OF DRUGS AND DNA AND ORGANELLE TARGETING
Torchilin, V. P. (2006) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.8.061505.095735 · Cited by 543
Seven challenges for nanomedicine
Sanhai, W. R., Sakamoto, J. H., Canady, R., & Ferrari, M. (2008) · Nature Nanotechnology · doi:10.1038/nnano.2008.114 · Cited by 538
Self-citationBiological applications of dendrimers
Cloninger, M. J. (2002) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(02)00400-3 · Cited by 516
Sparreboom, A., Scripture, C. D., Trieu, V., Williams, P. J., De, T., Yang, A., Beals, B., Figg, W. D., Hawkins, M., & Desai, N. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2291 · Cited by 504
Mammalian pharmacokinetics of carbon nanotubes using intrinsic near-infrared fluorescence
Cherukuri, P., Gannon, C. J., Leeuw, T. K., Schmidt, H. K., Smalley, R. E., Curley, S. A., & Weisman, R. B. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609265103 · Cited by 491
Gabizon, A., & Martin, F. (1997) · Drugs · doi:10.2165/00003495-199700544-00005 · Cited by 478
Morikawa, K., Walker, S. M., Nakajima, M., Pathak, S., Jessup, J. M., & Fidler, I. J. (1988) · PubMed · Cited by 474
Gabizon, A. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.01.011 · Cited by 464
The adhesive strength of non-spherical particles mediated by specific interactions
Decuzzi, P., & Ferrari, M. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.05.024 · Cited by 452
Self-citationCarbon nanotube‐enhanced thermal destruction of cancer cells in a noninvasive radiofrequency field
Gannon, C. J., Cherukuri, P., Yakobson, B. I., Cognet, L., Kanzius, J. S., Kittrell, C., Weisman, R. B., Pasquali, M., Schmidt, H. K., Smalley, R. E., et al. (2007) · Cancer · doi:10.1002/cncr.23155 · Cited by 449
Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo
Stroh, M., Zimmer, J. P., Duda, D. G., Levchenko, T. S., Cohen, K. S., Brown, E. B., Scadden, D. T., Torchilin, V. P., Bawendi, M. G., Fukumura, D., et al. (2005) · Nature Medicine · doi:10.1038/nm1247 · Cited by 432
Critical determinants of metastasis
Fidler, I. J. (2002) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0416 · Cited by 413
Demerec, M., Caspari, E. W., Thoday, J. M., et al. (1947) · Advances in genetics · Cited by 412
McKee, T. D., Grandi, P., Mok, W., Alexandrakis, G., Insin, N., Zimmer, J. P., Bawendi, M. G., Boucher, Y., Breakefield, X. O., & Jain, R. K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2242 · Cited by 397
Lyass, O., Uziely, B., Ben-Yosef, R., Tzemach, D., Heshing, N. I., Lotem, M., Brufman, G., & Gabizon, A. (2000) · Cancer · doi:10.1002/1097-0142(20000901)89:5<1037::aid-cncr13>3.0.co;2-z · Cited by 385
Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation
Johnsen, M., Lund, L. R., Rømer, J., Almholt, K., & Danø, K. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80044-6 · Cited by 356
Moen, M. D., Lyseng-Williamson, K. A., & Scott, L. J. (2009) · Drugs · doi:10.2165/00003495-200969030-00010 · Cited by 321
Dendrimer‐Entrapped Gold Nanoparticles as a Platform for Cancer‐Cell Targeting and Imaging
Shi, X., Wang, S., Meshinchi, S., Van Antwerp, M. E., Bi, X., Lee, I., & Baker, J. R. (2007) · Small · doi:10.1002/smll.200700054 · Cited by 318
(2024) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-031-52864-4 · Cited by 309
Gentile, F., Chiappini, C., Fine, D., Bhavane, R. C., Peluccio, M. S., Cheng, M. M.-C., Liu, X., Ferrari, M., & Decuzzi, P. (2008) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2008.03.021 · Cited by 304
Self-citation(2000) · PubMed · Cited by 295
Gabizón, A., & Martin, F. J. (1997) · Drugs · Cited by 293
Limitations of radiolabeled monoclonal antibodies for localization of human neoplasms.
Epenetos, A. A., Snook, D. E., Durbin, H., Johnson, P. M., & Taylor‐Papadimitriou, J. (1986) · PubMed · Cited by 284
Remotely Triggered Release from Magnetic Nanoparticles
Derfus, A. M., von Maltzahn, G., Harris, T. J., Duza, T., Vecchio, K. S., Ruoslahti, E., & Bhatia, S. N. (2007) · Advanced Materials · doi:10.1002/adma.200700091 · Cited by 282
A Theoretical Model for the Margination of Particles within Blood Vessels
Decuzzi, P., Lee, S., Bhushan, B., & Ferrari, M. (2005) · Annals of Biomedical Engineering · doi:10.1007/s10439-005-8976-5 · Cited by 280
Self-citationThe Receptor-Mediated Endocytosis of Nonspherical Particles
Decuzzi, P., & Ferrari, M. (2008) · Biophysical Journal · doi:10.1529/biophysj.107.120238 · Cited by 278
Self-citationThe role of specific and non-specific interactions in receptor-mediated endocytosis of nanoparticles
Decuzzi, P., & Ferrari, M. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.02.013 · Cited by 261
Self-citationPharmacokinetic variability of anticancer agents
Undevia, S. D., Gomez-Abuin, G., & Ratain, M. J. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1629 · Cited by 258
(1992) · PubMed · Cited by 252
(2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1171 · Cited by 219
Ferrari, M. (2008) · Nature Nanotechnology · doi:10.1038/nnano.2008.46 · Cited by 217
Self-citationYong, K.-T., Qian, J., Roy, I., Lee, H. H., Bergey, E. J., Tramposch, K. M., He, S., Swihart, M. T., Maitra, A., & Prasad, P. N. (2007) · Nano Letters · doi:10.1021/nl063031m · Cited by 196
Nanotechnology for breast cancer therapy
Tanaka, T., Decuzzi, P., Cristofanilli, M., Sakamoto, J. H., Tasciotti, E., Robertson, F. M., & Mauro Ferrari, B. (2008) · Biomedical Microdevices · doi:10.1007/s10544-008-9209-0 · Cited by 181
Blum, J. L., Savin, M. A., Edelman, G., Pippen, J. E., Robert, N. J., Geister, B. V., Kirby, R. L., Clawson, A., & O'Shaughnessy, J. A. (2007) · Clinical Breast Cancer · doi:10.3816/cbc.2007.n.049 · Cited by 172
Design maps for nanoparticles targeting the diseased microvasculature
Decuzzi, P., & Ferrari, M. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.09.025 · Cited by 168
Self-citationThe association of silicon microparticles with endothelial cells in drug delivery to the vasculature
Serda, R. E., Gu, J., Bhavane, R. C., Liu, X., Chiappini, C., Decuzzi, P., & Ferrari, M. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.01.019 · Cited by 163
Self-citationNeoadjuvant therapy for breast cancer
Liu, S. V., Melstrom, L., Yao, K., Russell, C. A., & Sener, S. F. (2010) · Journal of Surgical Oncology · doi:10.1002/jso.21446 · Cited by 162
Matrix Metalloproteinases-1 and -8 Improve the Distribution and Efficacy of an Oncolytic Virus
Mok, W., Boucher, Y., & Jain, R. K. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-3107 · Cited by 153
Yan, F., & Kopelman, R. (2003) · Photochemistry and Photobiology · doi:10.1562/0031-8655(2003)0780587teomis2.0.co2 · Cited by 149
Rosen, M. A., & Schnall, M. D. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1921 · Cited by 131
Green, J. J., Chiu, E., Leshchiner, E. S., Shi, J., Langer, R., & Anderson, D. G. (2007) · Nano Letters · doi:10.1021/nl062395b · Cited by 128
Liposomal Anthracyclines in Metastatic Breast Cancer: Clinical Update
Rivera, E. (2003) · The Oncologist · doi:10.1634/theoncologist.8-2004-3 · Cited by 128
Mathematical modeling of cancer progression and response to chemotherapy
Sanga, S., Sinek, J. P., Frieboes, H. B., Mauro Ferrari, B., Fruehauf, J. P., & Vittorio Cristini, C. (2006) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.6.10.1361 · Cited by 122
The Effective Dispersion of Nanovectors Within the Tumor Microvasculature
Decuzzi, P., Causa, F., Mauro Ferrari, B., & Netti, P. A. (2006) · Annals of Biomedical Engineering · doi:10.1007/s10439-005-9072-6 · Cited by 109
Innovations in avoiding particle clearance from blood by Kupffer cells: cause for reflection.
Moghimi, S. M., & Davis, S. S. (1994) · PubMed · Cited by 104
Henderson, I. C., & Bhatia, V. (2007) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.7.7.919 · Cited by 102
Koyama, Y., Barrett, T., Hama, Y., RAVIZZINI, G. C., Choyke, P. L., & Kobayashi, H. (2007) · Neoplasia · doi:10.1593/neo.07787 · Cited by 101
Design of bio-mimetic particles with enhanced vascular interaction
Lee, S., Mauro Ferrari, B., & Decuzzi, P. (2009) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2009.05.012 · Cited by 95
Mitotic trafficking of silicon microparticles
Serda, R. E., Ferrati, S., Godin, B., et al. (2009) · Nanoscale · doi:10.1039/b9nr00138g · Cited by 88
Tumor vasculature‐targeted delivery of tumor necrosis factor‐α*
Tandle, A. T., Hanna, E., Lorang, D., Hajitou, A., Moya, C. A., Pasqualini, R., Arap, W., Adem, A., Starker, E. Q., Hewitt, S. M., et al. (2008) · Cancer · doi:10.1002/cncr.24001 · Cited by 84
Mok, W., Stylianopoulos, T., Boucher, Y., & Jain, R. K. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2082 · Cited by 84
Oyewumi, M. O., & Mumper, R. J. (2002) · Bioconjugate Chemistry · doi:10.1021/bc025560x · Cited by 80
Antibiological barrier nanovector technology for cancer applications
Sakamoto, J. H., Annapragada, A., Decuzzi, P., & Mauro Ferrari, B. (2007) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.4.4.359 · Cited by 78
Tumour-selective drug delivery via folate receptor-targeted liposomes
Pan, X., & Lee, R. J. (2004) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.1.1.7 · Cited by 76
Lu, Y. J., Sega, E. I., & Low, P. S. (2005) · International Journal of Cancer · doi:10.1002/ijc.21126 · Cited by 73
An Integrated Approach for the Rational Design of Nanovectors for Biomedical Imaging and Therapy
Godin, B., Driessen, W. H. P., Proneth, B., Lee, S., Srinivasan, S., Rumbaut, R. E., Arap, W., Pasqualini, R., Mauro Ferrari, B., & Decuzzi, P. (2010) · Advances in genetics · doi:10.1016/s0065-2660(10)69009-8 · Cited by 60
Karadağ, A., Fedarko, N. S., & Fisher, L. W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2861 · Cited by 56
Peng, J., He, X., Wang, K., Tan, W., Li, H., Xing, X., & Wang, Y. (2006) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2006.04.003 · Cited by 56
Chemical modification and formulation approaches to elevated drug transport across cell membranes
Majumdar, S., & Mitra, A. K. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.4.511 · Cited by 51
Sun, C., Jain, R. K., & Munn, L. L. (2007) · Annals of Biomedical Engineering · doi:10.1007/s10439-007-9377-8 · Cited by 48
Yan, F., Xu, H., Anker, J. N., Kopelman, R., Ross, B. D., Rehemtulla, A., & Reddy, R. (2004) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2004.074 · Cited by 44
Martin, F. J., Melnik, K., West, T., Shapiro, J., Cohen, M., Boiarski, A. A., & Mauro Ferrari, B. (2005) · Drugs in R&D · doi:10.2165/00126839-200506020-00002 · Cited by 34
Molecular targets on blood vessels for cancer therapies in clinical trials.
Sato, M., Arap, W., & Pasqualini, R. (2007) · PubMed · Cited by 29
Cited by
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002
Self-citationSalvati, A., Pitek, A. S., Monopoli, M. P., Prapainop, K., Bombelli, F. B., Hristov, D. R., Kelly, P. M., Åberg, C., Mahon, E., & Dawson, K. A. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2012.237 · Cited by 1,912
Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery
Thomford, N. E., Senthebane, D. A., Rowe, A., Munro, D., Seele, P., Maroyi, A., & Dzobo, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061578 · Cited by 1,241
Cellular Uptake, Intracellular Trafficking, and Cytotoxicity of Nanomaterials
Zhao, F., Zhao, Y., Liu, Y., Chang, X., Chen, C., & Zhao, Y. (2011) · Small · doi:10.1002/smll.201100001 · Cited by 1,175
Parodi, A., Quattrocchi, N., van de Ven, A. L., Chiappini, C., Evangelopoulos, M., Martinez, J. O., Brown, B. S., Khaled, S. Z., Yazdi, I. K., Enzo, M. V., et al. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2012.212 · Cited by 1,168
Self-citation
Metadata
- Authors
- Ferrari, M.
- Venue
- Trends in Biotechnology
- Publisher
- Elsevier BV
- Published
- 2010-04
- Volume
- 28
- Issue
- 4
- Pages
- 181-188
- ISSN
- 0167-7799 (ISSN-L)
- OpenAlex
- W2063751734
- Cited by
- 255
- References
- 98
- FWCI
- 0.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.